Back to top

moving-average-crossover: Archive

Zacks Equity Research

Strength Seen in Waystar (WAY): Can Its 9.5% Jump Turn into More Strength?

Waystar (WAY) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

WAYNegative Net Change GRNDNegative Net Change

Zacks Equity Research

EPR Properties (EPR) Recently Broke Out Above the 20-Day Moving Average

Good things could be on the horizon when a stock surpasses the 20-day simple moving average. How should investors react?

EPRPositive Net Change

Zacks Equity Research

EPR Properties (EPR) Recently Broke Out Above the 50-Day Moving Average

Should investors be excited or worried when a stock crosses above the 50-Day simple moving average?

EPRPositive Net Change

Zacks Equity Research

Strength Seen in Honeywell International (HON): Can Its 3.7% Jump Turn into More Strength?

Honeywell International (HON) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.

HONPositive Net Change PKXPositive Net Change

Zacks Equity Research

Arcturus Therapeutics (ARCT) Stock Jumps 5.7%: Will It Continue to Soar?

Arcturus Therapeutics (ARCT) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

ARCTNegative Net Change ALKSNegative Net Change

Zacks Equity Research

Strength Seen in Paladin (PALAF): Can Its 5.4% Jump Turn into More Strength?

Paladin (PALAF) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

PALAFPositive Net Change NHYDYNegative Net Change

Zacks Equity Research

Foghorn Therapeutics (FHTX) Surges 5.8%: Is This an Indication of Further Gains?

Foghorn Therapeutics (FHTX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

FHTXNegative Net Change PRMENegative Net Change

Zacks Equity Research

Tarsus Pharmaceuticals (TARS) Moves 7.5% Higher: Will This Strength Last?

Tarsus Pharmaceuticals (TARS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

TARSNegative Net Change BCYCPositive Net Change

Zacks Equity Research

Genuine Parts (GPC) Moves 12.9% Higher: Will This Strength Last?

Genuine Parts (GPC) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

GPCPositive Net Change DRVNPositive Net Change

Zacks Equity Research

DLocal (DLO) Moves 12.9% Higher: Will This Strength Last?

DLocal (DLO) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

DLOPositive Net Change EEFTPositive Net Change